Cargando…
Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China
BACKGROUND: Familial hypercholesterolemia (FH), an autosomal dominant genetic disorder, is underdiagnosed and undertreated. The majority of FH cases are caused by low density lipoprotein receptor (LDL-R) gene mutations. The C308Y mutation in LDL-R results in approximately 70% loss of LDL-R activity,...
Autores principales: | Jin, Weirong, Zhang, Qiuwang, Wang, Bei, Pan, Lili, Qin, Hongyou, Yang, Daying, Zhou, Xiangqun, Du, Yongcai, Lin, Ling, Kutryk, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842482/ https://www.ncbi.nlm.nih.gov/pubmed/31706281 http://dx.doi.org/10.1186/s12881-019-0901-0 |
Ejemplares similares
-
Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011) -
Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
por: van El, Carla G., et al.
Publicado: (2018) -
Predictors of Family Enrollment in a Genetic Cascade Screening
Program for Familial Hypercholesterolemia
por: Silva, Pãmela Rodrigues de Souza, et al.
Publicado: (2018) -
Predictors of Family Recruitment in a Program of Genetic Cascade
Screening for Familial Hypercholesterolemia
por: Izar, Maria Cristina de Oliveira, et al.
Publicado: (2018) -
Genetic variations in familial hypercholesterolemia and cascade screening in East Asians
por: Chan, Melody Lok‐Yi, et al.
Publicado: (2018)